Skip to main content
. 2024 Jan 9;16(2):287. doi: 10.3390/cancers16020287

Figure 1.

Figure 1

Combined cohort: recurrence-free survival (RFS) and melanoma-specific survival (MSS) risk stratification by the 31-GEP and AJCC8 in stage I tumors. KM curves showing 5-year RFS (A) and MSS (B) among patients in the combined cohort based on 31-GEP result and AJCC8 stage.